245 related articles for article (PubMed ID: 19398707)
1. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR
Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.
Kantarci K; Petersen RC; Przybelski SA; Weigand SD; Shiung MM; Whitwell JL; Negash S; Ivnik RJ; Boeve BF; Knopman DS; Smith GE; Jack CR
Arch Neurol; 2008 Dec; 65(12):1621-8. PubMed ID: 19064749
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
5. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
Metastasio A; Rinaldi P; Tarducci R; Mariani E; Feliziani FT; Cherubini A; Pelliccioli GP; Gobbi G; Senin U; Mecocci P
Neurobiol Aging; 2006 Jul; 27(7):926-32. PubMed ID: 15936850
[TBL] [Abstract][Full Text] [Related]
6. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
Waragai M; Hata S; Suzuki T; Ishii R; Fujii C; Tokuda T; Arai H; Ohrui T; Higuchi S; Yoshida M; Igarashi K; Moriya M; Iwai N; Uemura K
J Alzheimers Dis; 2014; 41(4):1207-22. PubMed ID: 24787913
[TBL] [Abstract][Full Text] [Related]
7. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
9. MRI and MRS predictors of mild cognitive impairment in a population-based sample.
Kantarci K; Weigand SD; Przybelski SA; Preboske GM; Pankratz VS; Vemuri P; Senjem ML; Murphy MC; Gunter JL; Machulda MM; Ivnik RJ; Roberts RO; Boeve BF; Rocca WA; Knopman DS; Petersen RC; Jack CR
Neurology; 2013 Jul; 81(2):126-33. PubMed ID: 23761624
[TBL] [Abstract][Full Text] [Related]
10. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
11. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
Kantarci K; Jack CR; Xu YC; Campeau NG; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG; Petersen RC
Neurology; 2000 Jul; 55(2):210-7. PubMed ID: 10908893
[TBL] [Abstract][Full Text] [Related]
12. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
13. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS; Huang J; Chowdhury MH
J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
[TBL] [Abstract][Full Text] [Related]
14. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
[TBL] [Abstract][Full Text] [Related]
15. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ
Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.
Kantarci K; Weigand SD; Petersen RC; Boeve BF; Knopman DS; Gunter J; Reyes D; Shiung M; O'Brien PC; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
Neurobiol Aging; 2007 Sep; 28(9):1330-9. PubMed ID: 16860440
[TBL] [Abstract][Full Text] [Related]
17. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.
Capizzano AA; Schuff N; Amend DL; Tanabe JL; Norman D; Maudsley AA; Jagust W; Chui HC; Fein G; Segal MR; Weiner MW
AJNR Am J Neuroradiol; 2000 Apr; 21(4):621-30. PubMed ID: 10782769
[TBL] [Abstract][Full Text] [Related]
18. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of functional MRI markers in mild cognitive impairment.
Zhang B; Li M; Sun ZZ; Zhu B; Yuan L; Wang Y; Xu Y
J Clin Neurosci; 2009 May; 16(5):635-41. PubMed ID: 19264490
[TBL] [Abstract][Full Text] [Related]
20. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Pina MA
Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
